chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Was at work standing an my legs starting going numb with zero feelings.  Was in the Hosp for 6 days with out being able to know if i was going to the bathroom. It took 6 days of many cat scans of my entire body. On the 6th day they said a have an reaction from the Modena vaccine. It took 8 days before I had a bowel movement, And they had to induce it. I was in the Hosp for 12 days without Health Insurance so they said I has to go. I needed Acute therapy but no one would pay. I could not go home i have 20 Stairs to get to my apartment. So I had to go to my mothers house to live. Its been 1 1/2 months since I have been to my house so I had to give it up. My mother has me in therapy to teach me how to walk again. Still cant walk by my self.
Cindy had her COVID booster vaccine, and later that day she started to have flulike symptoms.  She went to bed but woke up later with violent chills.  She took Tylenol and went back to bed but her husband came to check on her and she was minimally conscious.  He could not get her out of bed.  Eventually was able to get her into the emergency department.  She basically has amnesia of the event.  An EKG was done showing lateral T wave inversions.  In reviewing her prior EKGs this is similar finding.  She was found to have a slight troponin elevation that was persistent over several days with no rise and fall.  She had an echocardiogram showing no evidence of a wall motion abnormality.  Ejection fraction was normal and there was no effusion.
Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 39-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 24-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter.  No treatment medication was provided by the reporter.  The Pharmacist reported administration of an expired  Moderna vaccine to patients of around 490 to 500 people on the date last Oct 20,2021 to Nov 29,2021.  Reporter has provided lot Number of vaccine as follows: 006C21A (10 Oct 2021), 026B21A (17 Sep 2021), and 031B21A (22 Sep 2021).  Reporter stated that vaccines were stored in freezer and used one to two vials which were placed in fridge each day as needed.
Patient developed HA apparently on the day of the vaccine.  Contacted the call center two days later, and subsequently had ED visits.  On 3/30 developed lethargy, and was brought to the ED.  CT scan showed nontraumatic subdural hematoma.
Chest pains, upper respiratory discomfort, tighness in upper body chest area, difficulty using upper limbs like opening a drawer or putting on socks became more and more painful.  stiffness in neck area.   Pain when breathing in deep.  Complications with ordinary movements like twist to put on seat belt. Terrible pain when trying to lift arms. When laying down or getting up was very painful and got worse over next few days.  Could not perform regular household duties like dishes or laundy due to muscle pain in chest when scrubbing even lightly or lifting arms to try and fold or hang up a shirt.
No adverse effects on day of vaccine or days following.  Today, 2/18/2021 feel swelling and warm to the touch at injection site
approx 15 individuals exp inject site pain on inject of Engerix-B; reporting nurse indicated that problem was remedied by warming the vax in hands a/inject was given; no further info is available; This case is considered to be invalid;
Initial misuse report received from a healthcare professional on 29 March 2013. Only diluent from the Acthib was administered to a patient without mixing the powder on it (no information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none.
Within an hour of receiving Pnuemovax child complained of leg pain. Within 36 hours he was unable to walk because of the pain and swelling. Right anterior thigh was red, warm, swollen and tender. He could not have clothes touch the area because of the pain. He was seen in the ER and given Benadryl, Tylenol with codeine and Clindamycin. He was already on Pencillin after a splenectomy.
The patient experienced a very sore arm the day after the injection.; She mentioned that it was very hard to move her arm. She continues to move it and gets getting better.; Feels like she has a big bruise on the arm.; This is a spontaneous report from a contactable reporter (consumer or other non-HCP).  A 20 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 06Jan2022 (Lot number: unknown) as dose 1, single for COVID-19 immunisation. It was unknown whether the patient had any relevant medical history. The patient's concomitant medications were not reported.  The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 07Jan2022, outcome "recovering", described as "The patient experienced a very sore arm the day after the injection"; MOVEMENT DISORDER (non-serious) with onset 07Jan2022, outcome "recovering", described as "She mentioned that it was very hard to move her arm. She continues to move it and gets getting better"; CONTUSION (non-serious) with onset 07Jan2022, outcome "recovering", described as "Feels like she has a big bruise on the arm". Therapeutic measures were not taken as a result of pain in extremity, movement disorder and contusion.  Additional Information: It was unknown whether the patient had any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Shot received 3:45pm 10/04/2005. By 8pm generalized over all feeling of not feeling well. Started getting chills and body aches from 9pm - 12:30am. When I took my temp 100.2. Took some Tylenol to try to reduce fever, went back to bed. Fever broke at around 5am. Had rash from shot site to under arms, around neck, across to under breast. Next day with tongue swelling and soreness and throat swelling. Had a cough like something was stuck in my throat the evening after shot.
Information unavialbe.  Patient died in home.  Covid 19 listed as cause of death on death certificate.
Information has been received from a certified nurse midwife (CNM) for a VARIVAX (Merck), a pregnancy registry product, concerning a 15 years old female patient with a history of gestational hypertension and 3 months of postpartum. No drug and allergies reactions were known, who on 18-MAR-2011, was vaccinated with a dose of VARIVAX (Merck) (lot # not reported). Unspecified pregnancy test was done on an unknown date and the nurse reported that the patient was pregnant and she had not had a period during the postpartum time. Estimated date of delivery was in 2011. The patient received unspecified medical attention. No adverse event was reported. Follow up information has been received from the CNM via complete pregnancy questionnaire concerning the 15 year old patient, with one previous full-term delivery pregnancy with no birth defects and no history of stillbirth or miscarriage in any previous pregnancies. It was reported that patient's last menstrual period was on 01-JAN-2011 and estimated delivery date 08-OCT-2011. The CNM also indicated that on an unspecified date, the patient was tested for varicella antibodies before vaccination with VZV containing vaccine, which resulted negative. The CNM reported that the patient had no local reaction at vaccination site. It was unknown if the patient had varicella/herpes zoster symptoms post vaccination. It was reported that there were no complications during pregnancy. The CNM also reported that on an unspecified date, the patient had an elective termination of pregnancy. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 50-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment medications were not provided by the reporter.
Nausea Vomiting Diarrhea  Headache  Dizziness (4 days)
2 1/2 hours after receiving 2nd shot, I developed total stiffness in back could barely stand up straight and had a stabbing, electric nerve pain down the L leg that was causing me to walk with a cane and take pain pills.  I am still with pain, can walk only short distances and feel fatigue and L leg shakes .  My gait is unsteady.
PT became weak and fainted following administration of vaccine. Reaction was approximately 1 minute following vaccine. Patients BG was taken and was significantly elevated 381. reaction likely related to blood glucose
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's medical history was not reported. On 11-NOV-2016, the patient was vaccinated with an expired dose of ZOSTAVAX lot # L027322, expiration date 21-OCT-2016 (dose, route and site of administration were not reported). Concomitant medications were not reported. No adverse effects were reported. Additional information has been requested.
This non-serious initial spontaneous case, was received from other health professional on 26-Nov-2017, concerning a male patient of age over 65-year-old. On an unspecified date (reported as 11-15 years ago), the patient received influenza vaccine, (dose, route of administration, anatomical location, batch number, expiry date, manufacturer and trade name: not reported). On an unspecified date, after the vaccination, the patient had fever, chills and weakness. The outcome of the events was not reported. The reporter considered the causality of the events as related to the suspect vaccine.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies provided. On 20-FEB-2017, the patient was vaccinated with improperly stored dose of M-M-R II rHA (recombinant human albumin) (lot# L049314 with expiration date 03-DEC-2017; site, dose and route of administration were not reported). The reason of the call was temperature alarm received via Digital Data Logger. It was reported that the vaccine was exposed to temperature of -14.4 Celsius degrees for 54 minutes before administration to the patient. No previous temperature excursion was reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected, all information has already been obtained. Sender's Comments: US-009507513-1611USA011831: US-009507513-1611USA004113: US-009507513-1705USA009742:
Presented to ED w/ c/o COVID symptoms; admitted w/COVID-19 pna, acute resp failure & sepsis; tx w/abx, Mag, Vit C, zinc; dc home
Pt called with the following symptoms 2 days after receiving Menactra:  numbness in her fingers, body aches, sweating, emesis, and difficulty moving her legs from the hips down.  It lasted for a half hour and resolved with motrin.  The next day she felt "foggy" and her affect was a bit off.  Pt was back to baseline the following day.
Chest pain, that worsened with deep breaths or leaning forward or backwards, dizziness, chest tightness. Tingling down left arm during duration of dizzy light headed feeling
This spontaneous report was received from a registered nurse concerning a female medical assistant of unknown age. On 21-JAN-2013, the medical assistant started administered a dose of ZOSTAVAX lot reported as H016737, exp date: 07-SEP-2014 (dose not reported) to a patient but some of the vaccine leaked out because she had not completely attached the needle to the syringe. Some of the ZOSTAVAX splashed onto the medical assistant's cheek. The medical assistant rinsed her cheek with water and she developed a rash on the same cheek. However, the rash had already disappeared and there were no symptoms at the time of the report. No other co-suspects were reported. No concomitant medications were reported. The relatedness for the event was unknown for ZOSTAVAX. This is one report of several reports from the same source (MARRS#1301USA012572). Additional information has been requested.
Patient was in the clinic for his 15 month well visit and was due for DTap and Hib. MA that administer vaccines accidentally gave patient a pediarix instead of a DTap.  No treatment was done.
Chest pain and choking sensation or mild asthma or dyspnea and sometimes tachycardia.
Patient was given correct shot (Moderna bivalent booster), however 0.25 mls was administered instead of 0.5 mls. Patient agreed to come back to the store 2 hour and 15 minutes later to have the second half of the shot administered in the same arm.
Narrative:  PATIENT REFUSED 2ND DOSE OF SHINGRIX STATING HE HAD CHILLS AND MYALGIAS AFTER 1ST DOSE.
Beginning at 3am on 2/27/21, high fever of 102.5, severe chills, severe body and leg aches, extreme fatigue. Took tylenol every 4 hours.  Fever up and down for the next 24 hours.  Fever finally broke 2/28/21 around noon.  Fatigued continued for approximately 4-5 days.  Today, 3/6/21, feeling back to normal.
Patient complains of pain and swollen under the armpit for about a week. He felt something hard like a" ball". It went away after a week with no other tissues. Patient did not seek any help or treatment because he felt better afterwards.
Information has been received from a pharmacist and a registered nurse concerning a patient who on an unspecified date was vaccinated with PNEUMOVAX 23 (Lot # 660717/0224X, exp. date: 11-SEP-2009) and developed injection site reactions. The pharmacist stated that the reactions included joint pain and immobility and were "over and beyond soreness". The pharmacist reported that he was not sure if it was the first or the second dose for the patient. The registered nurse reported that the reactions that the patient experienced were severe and the patient was hospitalized due to the reaction. A lot check has been requested by the registered nurse. Additional information has been requested.
In March 2021, I received an abnormal mammogram result. I had to go for a needle biopsy. The needle biopsy showed it was called DCIS and I was set up with an oncology surgeon. I had to have a lumpectomy in April 2021. After the lumpectomy, I had to meet with a medical and radiation oncologist. I had to have 16 radiation treatments. In July, I completed radiation I had to go back to the oncologist and was put on tamoxifen 20mg for the next years. There is no history of breast cancer in my family.
incapacitated and couldn't  get out of bed; Couldn't sleep; Chills; body aches; large red spot at the injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (incapacitated and couldn't  get out of bed), INSOMNIA (Couldn't sleep), CHILLS (Chills), MYALGIA (body aches) and VACCINATION SITE ERYTHEMA (large red spot at the injection site) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (incapacitated and couldn't  get out of bed), INSOMNIA (Couldn't sleep), CHILLS (Chills), MYALGIA (body aches) and VACCINATION SITE ERYTHEMA (large red spot at the injection site). At the time of the report, VACCINATION COMPLICATION (incapacitated and couldn't  get out of bed), INSOMNIA (Couldn't sleep), CHILLS (Chills), MYALGIA (body aches) and VACCINATION SITE ERYTHEMA (large red spot at the injection site) outcome was unknown.            No relevant concomitant medications were not reported It was reported that the patient received 1st dose on 12Feb2021 at 2:00 PM and after 12 hours he woke up and every part of his body hurt like he had been beaten with a bat. He took OTC medication Tylenol and within 20 minutes the pain feeling disappeared.  Treatment information was not provided by reporter
agitation; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of AGITATION (agitation) in an elderly patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AGITATION (agitation). At the time of the report, AGITATION (agitation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant and Treatment medication were reported.
This spontaneous report was received from a nurse and refers to a 4 month old patient of unknown gender. No information was provided regarding the patient's medical history, concurrent conditions, concomitant medications or drug reactions/allergies. On 26-MAR-2019, the patient received an improperly stored dose of LIQUID PEDVAXHIB, intramuscular, lot # R013571, expiration date 19-MAR-2021 for prophylaxis (dose was not reported) and ROTATEQ, orally, lot # R002701, expiration date 07-SEP-2019 for prophylaxis (dose was not reported) (product storage error). The administered dose of both vaccines experienced a temperature excursion above 47 degrees fahrenheit ° F/ 9 degrees Celsius ° C (12.6 C) for  4 hours and 45 minutes, as recorded by a data logger. The outcome of the event product storage error was not reported.
Patient received COVID bivalent booster as second dose in her series. Patient had only received one dose prior to this bivalent dose being given (on 12/10/2022).
Sore arm; fatigue; fever; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an unspecified route of administration in the left arm on 10Sep2021 (at the age of 34-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. On an unknown date in Sep2021, the patient experienced sore arm, fatigue and fever. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore arm, fatigue and fever was resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
FLU LIKE SYMPTOMS; SHIVERING/CHILLS; NAUSEA; HEADACHE; This spontaneous report received from a patient concerned a 58 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, expiry: UNKNOWN) dose was not reported, administered on 21-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On 21-MAR-2021, the subject experienced flu like symptoms. On 21-MAR-2021, the subject experienced shivering. On 21-MAR-2021, the subject experienced nausea. On 21-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms, shivering, nausea, and headache on 22-MAR-2021. This report was non-serious.
Fever lasting 2 days, injection site soreness, nausea, joint pain for 2 days, hair loss for 2 weeks, extreme fatigue for 2 weeks
This spontaneous report as received from a nurse practitioner refers to a 13 month old patient of an unknown gender. The patient's concurrent conditions and medical history were not reported. On 06-JAN-2016, the patient was vaccinated with VARIVAX (Merck) 0.5 ml subcutaneous lot # K001391 and expiry date of 29-JAN-2016 and PROQUAD (Merck) lot # K025760 with expiry date of 08-JUN-2016. No adverse effects were reported. Additional information has been requested.
Patient received the covid vaccine on 12/20/2020.  She tolerated the vaccine without problem. c/o new onset of stomach pain, diarrhea, nausea, and bodyache starting on 1/3/2021.  Symptoms persist today. No diarrhea today, 1/14/2021. LMP - 10/2020. Denies fever, cough, HA, any ocular symptom.   Covid test on 12/28/2020 was negative.
Same night the vaccine was given she had a very sore arm that was swollen. Also felt feverish, had coughing and difficulty breathing.
Pt came in for Covid Dose 2 of the 5-11 pfizer series.  1 nurse gave me the vial to mix (both monovalent and bivalent vials were in same box in frig) and I just took her word and did not reread label.  Instead of mixing monovalent covid I  mixed and administered the bivalent dose.  Error was not realized until charting was started.  Family had left.  Forecaster does not show error, but says we need to give 2nd monovalent dose in  January 2023.
Contracted symptomatic case of COVID-19. Symptoms began on August 9, 2021. Tested positive on August 10, 2021. Symptoms included: fever, muscle pain, dry cough, loss of sense of smell, congestion, headache